Aetion
Julie Paone, MPH, is an experienced scientist in epidemiology currently working at Aetion since April 2021. Prior to this role, Julie served as Program Manager for Oncology at Mount Sinai Health System, where responsibilities included enhancing patient access through data-driven insights and overseeing oncology referral processes. Previous positions include roles at Pfizer, where support was provided for Rare Disease product HEOR activities, and Hall & Partners, focusing on quantitative research for pharmaceutical and medical clients. Julie's educational background includes a Master of Public Health in Epidemiology and Comparative Effectiveness Outcomes Research from Columbia University Mailman School of Public Health and a Bachelor of Arts in Cognitive Science and Psychology from The Johns Hopkins University.
Aetion
9 followers
Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on treatments, costs, and outcomes. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era.